This company has shut down. ImVitro is no longer operating — its last tracked round was a Seed in 2022.
Explore the Startup GraveyardImVitro is a medical device developer that offers a SaaS platform that applies AI to In vitro fertilization imaging needs.
ImVitro has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
ImVitro's investors include Fly Ventures, MMC Ventures, LDV Capital, Compound, Tiny Supercomputer Investment Company.
ImVitro is headquartered in Paris, France.
ImVitro is a medical device developer that offers a SaaS platform that applies AI to In vitro fertilization imaging needs.
ImVitro is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImVitro — Funding & Investors." VCBacked, December 5, 2022, https://www.vcbacked.co/company/imvitro. Accessed August 15, 2026.
VCBacked. (2022). ImVitro — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/imvitro
{{cite web |title=ImVitro — Funding & Investors |url=https://www.vcbacked.co/company/imvitro |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated